Cargando…
RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAF(V600E) Mutation-Negative Nodules?
The object of this study is to evaluate the additional role of RAS mutation in detecting thyroid malignancy among BRAF(V600E) mutation-negative nodules diagnosed as atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) on cytology. From December 2009 to Decemb...
Autores principales: | Yoon, Jung Hyun, Kwon, Hyeong Ju, Lee, Hye Sun, Kim, Eun-Kyung, Moon, Hee Jung, Kwak, Jin Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504621/ https://www.ncbi.nlm.nih.gov/pubmed/26166089 http://dx.doi.org/10.1097/MD.0000000000001084 |
Ejemplares similares
-
Clinicopathological factors increased the risk of malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS
por: Hong, In Ki, et al.
Publicado: (2016) -
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017) -
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006) -
Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
por: Bayraktaroğlu, Taner, et al.
Publicado: (2023) -
Kallmann syndrome with a Tyr113His PROKR2 mutation
por: Ha, Jeong-Ha, et al.
Publicado: (2017)